HALO logo

Halozyme Therapeutics (HALO) Cost of goods sold

annual cost of goods sold:

$159.42M-$32.94M(-17.13%)
December 31, 2024

Summary

  • As of today (June 22, 2025), HALO annual cost of goods sold is $159.42 million, with the most recent change of -$32.94 million (-17.13%) on December 31, 2024.
  • During the last 3 years, HALO annual cost of goods sold has risen by +$78.00 million (+95.81%).
  • HALO annual cost of goods sold is now -17.13% below its all-time high of $192.36 million, reached on December 31, 2023.

Performance

HALO Cost of goods sold Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherHALOincome statement metrics

quarterly cost of goods sold:

$48.40M+$6.35M(+15.09%)
March 31, 2025

Summary

  • As of today (June 22, 2025), HALO quarterly cost of goods sold is $48.40 million, with the most recent change of +$6.35 million (+15.09%) on March 31, 2025.
  • Over the past year, HALO quarterly cost of goods sold has increased by +$20.07 million (+70.86%).
  • HALO quarterly cost of goods sold is now -11.71% below its all-time high of $54.82 million, reached on September 30, 2023.

Performance

HALO quarterly cost of goods sold Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherHALOincome statement metrics

TTM cost of goods sold:

$179.49M+$20.07M(+12.59%)
March 31, 2025

Summary

  • As of today (June 22, 2025), HALO TTM cost of goods sold is $179.49 million, with the most recent change of +$20.07 million (+12.59%) on March 31, 2025.
  • Over the past year, HALO TTM cost of goods sold has dropped by -$6.03 million (-3.25%).
  • HALO TTM cost of goods sold is now -6.69% below its all-time high of $192.36 million, reached on December 31, 2023.

Performance

HALO TTM cost of goods sold Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherHALOincome statement metrics

Cost of goods sold Formula

COGS = Beginning Inventory + Purchases − Ending Inventory

HALO Cost of goods sold Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-17.1%+70.9%-3.3%
3 y3 years+95.8%+204.0%+126.9%
5 y5 years+250.0%+736.4%+284.5%

HALO Cost of goods sold Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-17.1%+95.8%-11.7%+204.0%-6.7%+126.9%
5 y5-year-17.1%+267.6%-11.7%+769.3%-6.7%+431.3%
alltimeall time-17.1%>+9999.0%-11.7%>+9999.0%-6.7%>+9999.0%

HALO Cost of goods sold History

DateAnnualQuarterlyTTM
Mar 2025
-
$48.40M(+15.1%)
$179.49M(+12.6%)
Dec 2024
$159.42M(-17.1%)
$42.05M(-14.9%)
$159.42M(-6.0%)
Sep 2024
-
$49.43M(+24.8%)
$169.66M(-3.1%)
Jun 2024
-
$39.61M(+39.8%)
$175.06M(-5.6%)
Mar 2024
-
$28.33M(-45.8%)
$185.52M(-3.6%)
Dec 2023
$192.36M(+38.1%)
$52.30M(-4.6%)
$192.36M(+5.6%)
Sep 2023
-
$54.82M(+9.5%)
$182.18M(+4.3%)
Jun 2023
-
$50.07M(+42.4%)
$174.68M(+10.2%)
Mar 2023
-
$35.17M(-16.5%)
$158.55M(+13.8%)
Dec 2022
$139.30M(+71.1%)
$42.12M(-11.0%)
$139.30M(+17.3%)
Sep 2022
-
$47.32M(+39.4%)
$118.77M(+31.9%)
Jun 2022
-
$33.94M(+113.2%)
$90.04M(+13.8%)
Mar 2022
-
$15.92M(-26.2%)
$79.12M(-2.8%)
Dec 2021
$81.41M(+87.7%)
$21.59M(+16.1%)
$81.41M(-5.4%)
Sep 2021
-
$18.59M(-19.2%)
$86.10M(+17.8%)
Jun 2021
-
$23.02M(+26.3%)
$73.08M(+31.0%)
Mar 2021
-
$18.22M(-30.7%)
$55.80M(+28.7%)
Dec 2020
$43.37M(-4.8%)
$26.27M(+371.8%)
$43.37M(+28.4%)
Sep 2020
-
$5.57M(-3.0%)
$33.78M(-33.2%)
Jun 2020
-
$5.74M(-0.8%)
$50.55M(+8.3%)
Mar 2020
-
$5.79M(-65.3%)
$46.68M(+2.5%)
Dec 2019
$45.55M(+349.3%)
$16.69M(-25.3%)
$45.55M(+32.1%)
Sep 2019
-
$22.33M(+1089.8%)
$34.48M(+169.9%)
Jun 2019
-
$1.88M(-59.6%)
$12.77M(+8.9%)
Mar 2019
-
$4.65M(-17.3%)
$11.73M(+15.8%)
Dec 2018
$10.14M(-67.5%)
$5.62M(+798.1%)
$10.14M(-15.5%)
Sep 2018
-
$626.00K(-25.1%)
$12.00M(-39.1%)
Jun 2018
-
$836.00K(-72.6%)
$19.71M(-26.1%)
Mar 2018
-
$3.05M(-59.2%)
$26.66M(-14.4%)
Dec 2017
$31.15M(-6.2%)
$7.49M(-10.1%)
$31.15M(-1.6%)
Sep 2017
-
$8.33M(+7.0%)
$31.67M(-2.5%)
Jun 2017
-
$7.79M(+3.2%)
$32.47M(-1.6%)
Mar 2017
-
$7.54M(-5.7%)
$32.99M(-0.7%)
Dec 2016
$33.21M(+13.5%)
$8.00M(-12.4%)
$33.21M(-1.3%)
Sep 2016
-
$9.13M(+9.9%)
$33.63M(+9.6%)
Jun 2016
-
$8.31M(+7.0%)
$30.68M(+0.5%)
Mar 2016
-
$7.76M(-7.9%)
$30.51M(+4.3%)
Dec 2015
$29.25M(+28.7%)
$8.43M(+36.4%)
$29.25M(+8.5%)
Sep 2015
-
$6.18M(-24.1%)
$26.96M(+4.0%)
Jun 2015
-
$8.14M(+25.4%)
$25.93M(+9.4%)
Mar 2015
-
$6.49M(+5.6%)
$23.71M(+4.3%)
Dec 2014
$22.73M
$6.15M(+19.6%)
$22.73M(+13.0%)
DateAnnualQuarterlyTTM
Sep 2014
-
$5.14M(-13.2%)
$20.13M(+28.5%)
Jun 2014
-
$5.92M(+7.3%)
$15.67M(+42.1%)
Mar 2014
-
$5.52M(+55.9%)
$11.03M(+76.5%)
Dec 2013
$6.25M(+470.9%)
$3.54M(+418.3%)
$6.25M(+85.9%)
Sep 2013
-
$683.00K(-46.8%)
$3.36M(+15.7%)
Jun 2013
-
$1.28M(+73.7%)
$2.90M(+64.7%)
Mar 2013
-
$739.00K(+13.1%)
$1.76M(+61.1%)
Dec 2012
$1.09M(+324.4%)
$653.50K(+188.4%)
$1.09M(+120.3%)
Sep 2012
-
$226.60K(+58.4%)
$496.70K(+76.3%)
Jun 2012
-
$143.10K(+102.1%)
$281.80K(-11.1%)
Mar 2012
-
$70.80K(+26.0%)
$316.90K(+22.9%)
Dec 2011
$257.80K(-73.8%)
$56.20K(+380.3%)
$257.80K(-76.4%)
Sep 2011
-
$11.70K(-93.4%)
$1.09M(+0.4%)
Jun 2011
-
$178.20K(+1423.1%)
$1.09M(+9.6%)
Mar 2011
-
$11.70K(-98.7%)
$991.30K(+0.6%)
Dec 2010
$985.30K(+215.9%)
$888.90K(>+9900.0%)
$985.30K(+284.3%)
Sep 2010
-
$7200.00(-91.4%)
$256.40K(-27.1%)
Jun 2010
-
$83.50K(+1364.9%)
$351.80K(+12.3%)
Mar 2010
-
$5700.00(-96.4%)
$313.40K(+0.5%)
Dec 2009
$311.90K(-6.1%)
$160.00K(+55.9%)
$311.90K(+11.7%)
Sep 2009
-
$102.60K(+127.5%)
$279.20K(-9.1%)
Jun 2009
-
$45.10K(+973.8%)
$307.30K(+2.7%)
Mar 2009
-
$4200.00(-96.7%)
$299.30K(-9.9%)
Dec 2008
$332.30K(+38.2%)
$127.30K(-2.6%)
$332.30K(+41.9%)
Sep 2008
-
$130.70K(+252.3%)
$234.20K(+43.7%)
Jun 2008
-
$37.10K(-0.3%)
$163.00K(-19.1%)
Mar 2008
-
$37.20K(+27.4%)
$201.40K(-16.2%)
Dec 2007
$240.40K(-45.0%)
$29.20K(-50.9%)
$240.40K(-4.8%)
Sep 2007
-
$59.50K(-21.2%)
$252.60K(-54.0%)
Jun 2007
-
$75.50K(-0.9%)
$549.20K(+12.0%)
Mar 2007
-
$76.20K(+84.1%)
$490.20K(+12.2%)
Dec 2006
$437.00K(+740.4%)
$41.40K(-88.4%)
$437.00K(+4.9%)
Sep 2006
-
$356.10K(+2058.2%)
$416.50K(+490.8%)
Jun 2006
-
$16.50K(-28.3%)
$70.50K(-6.0%)
Mar 2006
-
$23.00K(+10.0%)
$75.00K(+44.2%)
Dec 2005
$52.00K(+227.0%)
$20.90K(+106.9%)
$52.00K(+67.2%)
Sep 2005
-
$10.10K(-51.9%)
$31.10K(+48.1%)
Jun 2005
-
$21.00K(-251.1%)
$21.00K(>+9900.0%)
Dec 2002
-
-$13.90K(-486.1%)
$0.00(-100.0%)
Sep 2002
-
$3600.00(-52.0%)
$13.90K(+35.0%)
Jun 2002
-
$7500.00(+167.9%)
$10.30K(+267.9%)
Mar 2002
-
$2800.00
$2800.00
Dec 2001
$15.90K
-
-

FAQ

  • What is Halozyme Therapeutics annual cost of goods sold?
  • What is the all time high annual cost of goods sold for Halozyme Therapeutics?
  • What is Halozyme Therapeutics annual cost of goods sold year-on-year change?
  • What is Halozyme Therapeutics quarterly cost of goods sold?
  • What is the all time high quarterly cost of goods sold for Halozyme Therapeutics?
  • What is Halozyme Therapeutics quarterly cost of goods sold year-on-year change?
  • What is Halozyme Therapeutics TTM cost of goods sold?
  • What is the all time high TTM cost of goods sold for Halozyme Therapeutics?
  • What is Halozyme Therapeutics TTM cost of goods sold year-on-year change?

What is Halozyme Therapeutics annual cost of goods sold?

The current annual cost of goods sold of HALO is $159.42M

What is the all time high annual cost of goods sold for Halozyme Therapeutics?

Halozyme Therapeutics all-time high annual cost of goods sold is $192.36M

What is Halozyme Therapeutics annual cost of goods sold year-on-year change?

Over the past year, HALO annual cost of goods sold has changed by -$32.94M (-17.13%)

What is Halozyme Therapeutics quarterly cost of goods sold?

The current quarterly cost of goods sold of HALO is $48.40M

What is the all time high quarterly cost of goods sold for Halozyme Therapeutics?

Halozyme Therapeutics all-time high quarterly cost of goods sold is $54.82M

What is Halozyme Therapeutics quarterly cost of goods sold year-on-year change?

Over the past year, HALO quarterly cost of goods sold has changed by +$20.07M (+70.86%)

What is Halozyme Therapeutics TTM cost of goods sold?

The current TTM cost of goods sold of HALO is $179.49M

What is the all time high TTM cost of goods sold for Halozyme Therapeutics?

Halozyme Therapeutics all-time high TTM cost of goods sold is $192.36M

What is Halozyme Therapeutics TTM cost of goods sold year-on-year change?

Over the past year, HALO TTM cost of goods sold has changed by -$6.03M (-3.25%)
On this page